VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 75 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $61,667 | +39.9% | 494,520 | +15.6% | 0.00% | – |
| Q4 2022 | $44,078 | -33.2% | 427,939 | 0.0% | 0.00% | – |
| Q3 2022 | $66,000 | -86.1% | 427,939 | -20.9% | 0.00% | – |
| Q2 2022 | $476,000 | -30.6% | 540,747 | -2.3% | 0.00% | – |
| Q1 2022 | $686,000 | -27.6% | 553,201 | +14.0% | 0.00% | – |
| Q4 2021 | $947,000 | -28.8% | 485,417 | +0.1% | 0.00% | – |
| Q3 2021 | $1,330,000 | -11.0% | 485,104 | +2.3% | 0.00% | – |
| Q2 2021 | $1,495,000 | +1297.2% | 474,361 | +853.0% | 0.00% | – |
| Q1 2021 | $107,000 | – | 49,777 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Performa Ltd (US), LLC | 4,900 | $9,163 | 0.01% |